EMAIL THIS PAGE TO A FRIEND

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Miconazole mucoadhesive tablets: a novel delivery system.


PMID 22495075

Abstract

Oropharyngeal candidiasis (OPC) is among the most common opportunistic infections observed in persons infected with human immunodeficiency virus. A once-daily miconazole 50 mg mucoadhesive buccal tablet (MBT) is a novel delivery system with potent in vitro activity against many Candida species, including some that may be resistant to other azoles. MBT, although more expensive, offers an effective, safe, and well-tolerated topical treatment option for OPC that is administered as a convenient once-daily dose.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

M1880000 Miconazole, European Pharmacopoeia (EP) Reference Standard
C18H14Cl4N2O